Update in Antiepidermal Growth Factor Receptor Therapy in the Management of Metastatic Colorectal Cancer

The approval of anti-epidermal growth factor receptor (EGFR) monoclonal antibodies in the treatment of metastatic colorectal cancer (CRC) has expanded the armamentarium against this disease. This paper will review the historical progress and recent clinical developments of anti-EGFR therapies in the...

Descripción completa

Detalles Bibliográficos
Autores principales: Loong, Herbert H., Ma, Brigette B., Chan, Anthony T. C.
Formato: Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2009
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2667934/
https://www.ncbi.nlm.nih.gov/pubmed/19365583
http://dx.doi.org/10.1155/2009/967920

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2667934/
https://www.ncbi.nlm.nih.gov/pubmed/19365583
http://dx.doi.org/10.1155/2009/967920

Ejemplares similares